Clinical efficacy and safety of targeted therapy, immunotherapy combined with chemotherapy for treating patients with advanced gastric cancer
The therapeutic regimen of apatinib, a PD-1 inhibitor combined with chemotherapy exhibits relatively high clinical efficacy and safety for the treatment of patients with advanced gastric cancer. It can be considered as an interventional option for this type of patient.
Authors
- Zhilong Gao (ORCID: https://orcid.org/0000-0001-7783-049X)
- Xuezhu Yang
- Liguo Gao
- Dongyan Yang
Institutions
- Hubei University of Medicine (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-09-09
- DOI
- https://doi.org/10.12669/pjms.40.9.9049
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42